Clinical Trial Update: Determination of the Antidepressant Duloxetine in Plasma to Improve the Knowledge of the Analgesic Action of Antidepressants on Chronic Neuropathic Pain [Phase 4]

View source ↗

Summary

A Phase 4 trial studying the relationship between plasma duloxetine levels and analgesic effect in chronic neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Neuropathic Pain | Phase 4 | Status: COMPLETED